A Study of JMT203 in Patients With Cancer Cachexia

A Phase Ia/II, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of JMT203 in Patients with Cancer Cachexia

Trial Details

NCT ID
NCT06868849
Phase
PHASE1 / PHASE2
Sponsor
Shanghai JMT-Bio Inc.
Status
RECRUITING
Cancer Type
Lung Cancer
Interventions
  • JMT203 Injection
Locations (sample)
  • Zhejiang, China|25.3238,105.583

Key Eligibility Criteria

  • Inclusion Criteria:
  • Age ≥ 18 years old;
  • Voluntarily participate in the study and sign the informed consent form;
  • Inclusion Criteria:

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lung Cancer Trials on Trialify →